Johnson & Johnson posts mixed 3Q results
Johnson & Johnson, continuing a tough year of declining revenue, posted a 29 percent drop in third-quarter earnings as it was hammered by plunging sales of its hepatitis C medicine and unfavorable currency exchange rates.
The healthcare bellwether’s results were also hurt by comparison to a year-ago when it had a $2 billion gain from selling a large diagnostics business.
Money & Markets
US stocks hang near their record as Wall Street takes a breath following two big days
NEW YORK — U.S. stocks hung near their all-time high on Wednesday as financial markets caught a breath following ...
US stocks approach their all-time high as oil prices tumble
NEW YORK — U.S. stocks rose toward their all-time high on Tuesday after oil prices eased further on hopes that ...
Apple unveils software redesign while reeling from AI missteps, tech upheaval and Trump’s trade war
the associated press CUPERTINO, Calif. — After stumbling out of the starting gate in Big Tech’s pivotal race ...
Stop making cents: US Mint moves forward with plans to kill the penny
Trump keeps 10% tariffs on UK but cuts taxes on British autos, steel and aluminum with trade deal
WASHINGTON — President Donald Trump agreed Thursday to cut tariffs on U.K. autos, steel and aluminum in a planned ...
